Epoch Investment Partners, Inc. Astrazeneca PLC Transaction History
Epoch Investment Partners, Inc.
- $21.7 Billion
- Q3 2024
A detailed history of Epoch Investment Partners, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 1,962,030 shares of AZN stock, worth $140 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
1,962,030
Previous 2,289,057
14.29%
Holding current value
$140 Million
Previous $179 Million
14.36%
% of portfolio
0.71%
Previous 0.84%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,335Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.48 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.99 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.65 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.62 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...